4-(Indolyl-3)-1-(benzimidazolonylalkyl)-piperidines, a novel group of potential antiallergy compounds

Arzneimittelforschung. 1985;35(1A):272-6. doi: 10.1002/chin.198528212.

Abstract

A group of indolyl-benzimidazolone-piperidines is described and the structure-activity with reference to the passive cutaneous anaphylaxis (PCA) in rats is discussed. Compound 7b, 4-(indolyl-3)-1-(benzimidazolonyl-propyl)-piperidine, which has the highest potency in this test, was studied in more detail with regard to antihistaminic and secretory cell stabilization properties.

MeSH terms

  • Animals
  • Basophils / metabolism
  • Benzimidazoles / chemical synthesis*
  • Benzimidazoles / pharmacology
  • Guinea Pigs
  • Histamine H1 Antagonists / chemical synthesis*
  • Histamine Release / drug effects
  • Humans
  • In Vitro Techniques
  • Male
  • Mast Cells / drug effects
  • Muscle Contraction / drug effects
  • Muscle, Smooth / drug effects
  • Passive Cutaneous Anaphylaxis / drug effects
  • Peritoneal Cavity / cytology
  • Piperidines / chemical synthesis*
  • Piperidines / pharmacology
  • Rats
  • Rats, Inbred Strains
  • Structure-Activity Relationship

Substances

  • Benzimidazoles
  • Histamine H1 Antagonists
  • Piperidines